Home
Life Sciences
Healthcare
General Medicine and Specialty Medicine
Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

General Medicine & Spec

Summary

Table of Contents

Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Publication date: May 2012
Report size: 129 pages

Keywords : interventional neurology, neurology

Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others Summary GlobalData’s new report, “Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides key market data on the Australia Neurology Devices market. The ...

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles

» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Summary

GlobalData’s new report, “Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides key market data on the Australia Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the six market categories.
- Global corporate-level profiles of key companies operating within the Australia Neurology Devices market.
- Key players covered include Medtronic, Inc., DePuy, Inc., Covidien plc, Stryker Corporation, Terumo Corporation, B. Braun Melsungen AG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Australia Neurology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

General Medicine And Specialty Medicine Industry in Australia

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
3 Neurology Devices In Australia 12
3.1 Neurology Devices, Market Segmentation 12
3.2 Neurology Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 13
3.3 Neurology Devices Market, Australia, Revenue Mix ($m), 2011 14
3.4 Neurology Devices Market, Australia, Category Contribution (%), 2011 15
3.5 Neurology Devices, Australia, Company Share (2010-2011) 21
4 CSF Management In Australia 23
4.1 CSF Management, Market Segmentation 23
4.2 CSF Management Market, Australia, Revenue Mix ($m), 2011 24
4.3 CSF Management Market, Australia, Segment Contribution (%), 2011 25
4.4 CSF Management Overall Revenue, (2004-2018) 26
4.5 CSF Management Overall Volume (2004-2018) 30
4.6 CSF Management Average Price (2004-2018) 32
4.7 CSF Management Distribution Share (2010-2011) 33
4.8 CSF Management, Australia, Company Share (2010-2011) 34
5 Interventional Neurology In Australia 36
5.1 Interventional Neurology, Market.Segmentation 36
5.2 Interventional Neurology Market, Australia, Revenue Mix ($m), 2011 37
5.3 Interventional Neurology Market, Australia, Segment Contribution (%), 2011 38
5.4 Interventional Neurology Overall Revenue, (2004-2018) 39
5.4.1 Embolic Systems, Revenue (2004-2018) 43
5.4.2 Navigational Systems, Revenue (2004-2018) 47
5.5 Interventional Neurology Overall Volume (2004-2018) 51
5.5.1 Embolic Systems, Volume (2004-2018) 54
5.5.2 Navigational Systems, Volume (2004-2018) 56
5.6 Interventional Neurology Average Price (2004-2018) 58
5.7 Interventional Neurology Distribution Share (2010-2011) 59
5.8 Interventional Neurology, Australia, Company Share (2010-2011) 60
6 Neurological Diagnostic Equipment In Australia 62
6.1 Neurological Diagnostic Equipment, Market.Segmentation 62
6.2 Neurological Diagnostic Equipment Market, Australia, Revenue Mix ($m), 2011 63
6.3 Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2011 64
6.4 Neurological Diagnostic Equipment Overall Revenue, (2004-2018) 65
6.5 Neurological Diagnostic Equipment Overall Volume (2004-2018) 69
6.6 Neurological Diagnostic Equipment Average Price (2004-2018) 73
6.7 Neurological Diagnostic Equipment Distribution Share (2010-2011) 74
6.8 Neurological Diagnostic Equipment, Australia, Company Share (2010-2011) 75
7 Neurostimulation Devices In Australia 77
7.1 Neurostimulation Devices, Market Segmentation 77
7.2 Neurostimulation Devices Market, Australia, Revenue Mix ($m), 2011 78
7.3 Neurostimulation Devices Market, Australia, Segment Contribution (%), 2011 79
7.4 Neurostimulation Devices Overall Revenue, (2004-2018) 80
7.5 Neurostimulation Devices Overall Volume (2004-2018) 84
7.6 Neurostimulation Devices Average Price (2004-2018) 88
7.7 Neurostimulation Devices Distribution Share (2010-2011) 89
7.8 Neurostimulation Devices, Australia, Company Share (2010-2011) 90
8 Neurosurgical Products In Australia 91
8.1 Neurosurgical Products, Market Segmentation 91
8.2 Neurosurgical Products Market, Australia, Revenue Mix ($m), 2011 92
8.3 Neurosurgical Products Market, Australia, Segment Contribution (%), 2011 93
8.4 Neurosurgical Products Overall Revenue, (2004-2018) 94
8.5 Neurosurgical Products Overall Volume (2004-2018) 98
8.6 Neurosurgical Products Average Price (2004-2018) 100
8.7 Neurosurgical Products Distribution Share (2010-2011) 101
8.8 Neurosurgical Products, Australia, Company Share (2010-2011) 102
9 Radiosurgery In Australia 103
9.1 Radiosurgery Overall Revenue, (2004-2011) 103
9.2 Radiosurgery Overall Volume (2004-2011) 104
9.3 Radiosurgery Average Price (2004-2011) 105
10 Overview of Key Companies in Australia Neurology Devices Market 106
10.1 Medtronic, Inc. 106
10.1.1 Company Overview 106
10.1.2 Share in the Australia Neurology Devices Market 106
10.2 DePuy, Inc. 107
10.2.1 Company Overview 107
10.2.2 Share in the Australia Neurology Devices Market 107
10.3 Covidien plc 108
10.3.1 Company Overview 108
10.3.2 Share in the Australia Neurology Devices Market 108
10.4 Stryker Corporation 109
10.4.1 Company Overview 109
10.4.2 Share in the Australia Neurology Devices Market 109
10.5 Terumo Corporation 110
10.5.1 Company Overview 110
10.5.2 Share in the Australia Neurology Devices Market 110
10.6 B. Braun Melsungen AG 111
10.6.1 Company Overview 111
10.6.2 Share in the Australia Neurology Devices Market 111
10.7 CareFusion Corporation 112
10.7.1 Company Overview 112
10.8 St. Jude Medical, Inc. 112
10.8.1 Company Overview 112
10.9 Compumedics Limited 113
10.9.1 Company Overview 113
10.10 Natus Medical Incorporated 113
10.10.1 Company Overview 113
10.11 Cadwell Laboratories, Inc. 113
10.11.1 Company Overview 113
10.12 Integra LifeSciences Holdings Corporation 114
10.12.1 Company Overview 114
10.13 Nihon Kohden Corporation 114
10.13.1 Company Overview 114
10.14 Boston Scientific Corporation 115
10.14.1 Company Overview 115
10.15 Christoph Miethke GmbH & Co. KG 115
10.15.1 Company Overview 115
10.16 Sophysa S.A. 115
10.16.1 Company Overview 115
10.17 Mizuho Ikakogyo Co., Ltd. 116
10.17.1 Company Overview 116
10.18 Cyberonics, Inc. 116
10.18.1 Company Overview 116
10.19 KARL STORZ GmbH & Co. KG 116
10.19.1 Company Overview 116
11 Neurology Devices Market Pipeline Products 117
12 Appendix 122
12.1 Definitions of Markets Covered in the Report 123
12.1.1 Neurology Devices 123
12.2 Research Methodology 127
12.3 Secondary Research 127
12.4 Primary Research 127
12.5 Models 128
12.6 Forecasts 128
12.7 Expert Panels 129
12.8 GlobalData Consulting 129
12.9 Currency Conversion 129
12.10 Contact Us 129
12.11 Disclaimer 129

List of Tables

Table 1: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 13
Table 2: Neurology Devices Market, Australia, Category Contribution (%), 2011 15
Table 3: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 16
Table 4: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 18
Table 5: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 20
Table 6: Neurology Devices, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 22
Table 7: CSF Management Market, Australia, Segment Contribution (%), 2011 25
Table 8: CSF Management, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 27
Table 9: CSF Management, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 29
Table 10: CSF Management, Australia, Volume (Units) by Segment, Historic, 2004-2011 30
Table 11: CSF Management, Australia, Volume (Units) by Segment, Forecast, 2011-2018 31
Table 12: CSF Management, Australia, Average Price ($), Historic, 2004-2011 32
Table 13: CSF Management, Australia, Average Price ($), Forecast, 2011-2018 32
Table 14: CSF Management, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 33
Table 15: CSF Management, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 35
Table 16: Interventional Neurology Market, Australia, Segment Contribution (%), 2011 38
Table 17: Interventional Neurology, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 40
Table 18: Interventional Neurology, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 42
Table 19: Embolic Systems, Australia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 44
Table 20: Embolic Systems, Australia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 46
Table 21: Navigational Systems, Australia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 48
Table 22: Navigational Systems, Australia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 50
Table 23: Interventional Neurology, Australia, Volume (Units) by Segment, Historic, 2004-2011 52
Table 24: Interventional Neurology, Australia, Volume (Units) by Segment, Forecast, 2011-2018 53
Table 25: Embolic Systems, Australia, Volume (Units) by Sub-Segment, Historic, 2004-2011 54
Table 26: Embolic Systems, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-2018 55
Table 27: Navigational Systems, Australia, Volume (Units) by Sub-Segment, Historic, 2004-2011 56
Table 28: Navigational Systems, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-2018 57
Table 29: Interventional Neurology, Australia, Average Price ($), Historic, 2004-2011 58
Table 30: Interventional Neurology, Australia, Average Price ($), Forecast, 2011-2018 58
Table 31: Interventional Neurology, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59
Table 32: Interventional Neurology, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 61
Table 33: Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2011 64
Table 34: Neurological Diagnostic Equipment, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 66
Table 35: Neurological Diagnostic Equipment, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 68
Table 36: Neurological Diagnostic Equipment, Australia, Volume (Units) by Segment, Historic, 2004-2011 70
Table 37: Neurological Diagnostic Equipment, Australia, Volume (Units) by Segment, Forecast, 2011-2018 72
Table 38: Neurological Diagnostic Equipment, Australia, Average Price ($), Historic, 2004-2011 73
Table 39: Neurological Diagnostic Equipment, Australia, Average Price ($), Forecast, 2011-2018 73
Table 40: Neurological Diagnostic Equipment, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 74
Table 41: Neurological Diagnostic Equipment, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 76
Table 42: Neurostimulation Devices Market, Australia, Segment Contribution (%), 2011 79
Table 43: Neurostimulation Devices, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 81
Table 44: Neurostimulation Devices, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 83
Table 45: Neurostimulation Devices, Australia, Volume (Units) by Segment, Historic, 2004-2011 85
Table 46: Neurostimulation Devices, Australia, Volume (Units) by Segment, Forecast, 2011-2018 87
Table 47: Neurostimulation Devices, Australia, Average Price ($), Historic, 2004-2011 88
Table 48: Neurostimulation Devices, Australia, Average Price ($), Forecast, 2011-2018 88
Table 49: Neurostimulation Devices, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 89
Table 50: Neurostimulation Devices, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 90
Table 51: Neurosurgical Products Market, Australia, Segment Contribution (%), 2011 93
Table 52: Neurosurgical Products, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 95
Table 53: Neurosurgical Products, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 97
Table 54: Neurosurgical Products, Australia, Volume (Units) by Segment, Historic, 2004-2011 98
Table 55: Neurosurgical Products, Australia, Volume (Units) by Segment, Forecast, 2011-2018 99
Table 56: Neurosurgical Products, Australia, Average Price ($), Historic, 2004-2011 100
Table 57: Neurosurgical Products, Australia, Average Price ($), Forecast, 2011-2018 100
Table 58: Neurosurgical Products, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 101
Table 59: Neurosurgical Products, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 102
Table 60: Radiosurgery (GammaKnife Radiosurgery), Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 103
Table 61: Radiosurgery (GammaKnife Radiosurgery), Australia, Volume (Units) by Segment, Historic, 2004-2011 104
Table 62: Radiosurgery (GammaKnife Radiosurgery), Australia, Average Price ($), Historic, 2004-2011 105
Table 63: Neurology DevicesMarket Pipeline Products 117

List of Figures

Figure 1: Neurology Devices, Market Segmentation 12
Figure 2: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 13
Figure 3: Neurology Devices Market, Australia, Revenue Mix ($m), 2011 14
Figure 4: Neurology Devices Market, Australia, Category Contribution (%), 2011 15
Figure 5: Neurology Devices, Australia, Cross-Category Analysis, 2004-2018 16
Figure 6: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17
Figure 7: Neurology Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19
Figure 8: Neurology Devices, Australia, Company Share (%), 2011 21
Figure 9: CSF Management, Market Segmentation 23
Figure 10: CSF Management Market, Australia, Revenue Mix ($m), 2011 24
Figure 11: CSF Management Market, Australia, Segment Contribution (%), 2011 25
Figure 12: CSF Management, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 26
Figure 13: CSF Management, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 28
Figure 14: CSF Management, Australia, Volume (Units) by Segment, Historic, 2004-2011 30
Figure 15: CSF Management, Australia, Volume (Units) by Segment, Forecast, 2011-2018 31
Figure 16: CSF Management, Australia, Company Share (%), 2011 34
Figure 17: Interventional Neurology, Market Segmentation 36
Figure 18: Interventional Neurology Market, Australia, Revenue Mix ($m), 2011 37
Figure 19: Interventional Neurology Market, Australia, Segment Contribution (%), 2011 38
Figure 20: Interventional Neurology, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 39
Figure 21: Interventional Neurology, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 41
Figure 22: Embolic Systems, Australia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 43
Figure 23: Embolic Systems, Australia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 45
Figure 24: Navigational Systems, Australia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 47
Figure 25: Navigational Systems, Australia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 49
Figure 26: Interventional Neurology, Australia, Volume (Units) by Segment, Historic, 2004-2011 51
Figure 27: Interventional Neurology, Australia, Volume (Units) by Segment, Forecast, 2011-2018 53
Figure 28: Embolic Systems, Australia, Volume (Units) by Sub-Segment, Historic, 2004-2011 54
Figure 29: Embolic Systems, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-2018 55
Figure 30: Navigational Systems, Australia, Volume (Units) by Sub-Segment, Historic, 2004-2011 56
Figure 31: Navigational Systems, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-2018 57
Figure 32: Interventional Neurology, Australia, Company Share (%), 2011 60
Figure 33: Neurological Diagnostic Equipment, Market Segmentation 62
Figure 34: Neurological Diagnostic Equipment Market, Australia, Revenue Mix ($m), 2011 63
Figure 35: Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2011 64
Figure 36: Neurological Diagnostic Equipment, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 65
Figure 37: Neurological Diagnostic Equipment, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 67
Figure 38: Neurological Diagnostic Equipment, Australia, Volume (Units) by Segment, Historic, 2004-2011 69
Figure 39: Neurological Diagnostic Equipment, Australia, Volume (Units) by Segment, Forecast, 2011-2018 71
Figure 40: Neurological Diagnostic Equipment, Australia, Company Share (%), 2011 75
Figure 41: Neurostimulation Devices, Market Segmentation 77
Figure 42: Neurostimulation Devices Market, Australia, Revenue Mix ($m), 2011 78
Figure 43: Neurostimulation Devices Market, Australia, Segment Contribution (%), 2011 79
Figure 44: Neurostimulation Devices, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 80
Figure 45: Neurostimulation Devices, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 82
Figure 46: Neurostimulation Devices, Australia, Volume (Units) by Segment, Historic, 2004-2011 84
Figure 47: Neurostimulation Devices, Australia, Volume (Units) by Segment, Forecast, 2011-2018 86
Figure 48: Neurostimulation Devices, Australia, Company Share (%), 2011 90
Figure 49: Neurosurgical Products, Market Segmentation 91
Figure 50: Neurosurgical Products Market, Australia, Revenue Mix ($m), 2011 92
Figure 51: Neurosurgical Products Market, Australia, Segment Contribution (%), 2011 93
Figure 52: Neurosurgical Products, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 94
Figure 53: Neurosurgical Products, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 96
Figure 54: Neurosurgical Products, Australia, Volume (Units) by Segment, Historic, 2004-2011 98
Figure 55: Neurosurgical Products, Australia, Volume (Units) by Segment, Forecast, 2011-2018 99
Figure 56: Neurosurgical Products, Australia, Company Share (%), 2011 102
Figure 57: Radiosurgery (GammaKnife Radiosurgery), Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 103
Figure 58: Radiosurgery (GammaKnife Radiosurgery), Australia, Volume (Units) by Segment, Historic, 2004-2011 104
Figure 59: Medtronic, Inc., Company Share (%),Australia Neurology Devices Market, 2011 106
Figure 60: DePuy, Inc., Company Share (%),Australia Neurology Devices Market, 2011 107
Figure 61: Covidien plc, Inc., Company Share (%),Australia Neurology Devices Market, 2011 108
Figure 62: Stryker Corporation, Company Share (%),Australia Neurology Devices Market, 2011 109
Figure 63: Terumo Corporation, Company Share (%),Australia Neurology Devices Market, 2011 110
Figure 64: B. Braun Melsungen AG, Company Share (%),Australia Neurology Devices Market, 2011 111

Companies mentioned
Medtronic, Inc.
DePuy, Inc.
Covidien plc
Stryker Corporation
Terumo Corporation
B. Braun Melsungen AG
CareFusion Corporation
St. Jude Medical, Inc.
Compumedics Limited
Natus Medical Incorporated
Cadwell Laboratories, Inc.
Integra LifeScience

Talk to Alison

00 1 718 618 48 97

Send Your Request

Follow

Add to circles Subscribe to our RSS feeds!

General Medicine And Specialty Medicine Industry in Australia : Latest Reports

EpiCast Report: Postmenopausal Vaginal Atrophy - Epidemiology Forecast to 2022

$ 3 995
Industry report
March 2013
by Global Data

EpiCast Report: Postmenopausal Vaginal Atrophy - Epidemiology Forecast to 2022 Summary The urogenital tract, specifically the vagina, urethra, bladder, trigone of the bladder, and pelvic floor muscles, ...

Analytical Tool - Apoptosis in Oncology

$ 4 650
Industry report
April 2013
by Bioseeker

"Analytical Tool - Apoptosis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer. It is ...

Analytical Tool - Angiogenesis in Oncology

$ 4 650
Industry report
April 2013
by Bioseeker

"Analytical Tool - Angiogenesis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in anti-angiogenic drug development for the treatment of cancer. ...

Analytical Tool - Peptides In Oncology

April 2013 $ 4 650

Pharmaceutical & Healthcare Annual Deals A ...

March 2013 $ 3 500

Preclinical Stage Partnering Terms And Agr ...

May 2013 $ 2 995

Gastrointestinal Devices: World Market 201 ...

March 2013 $ 2 732

Global Eye Care Market 2012-2016

March 2013 $ 2 000

Global Eye Care Surgical Market 2012-201 ...

April 2013 $ 2 000

Analyzing Robotics In Healthcare

May 2013 $ 500

More Reports:

General Medicine and Specialty Medicine in Australia (11)

General Medicine and Spe... in China (19)

General Medicine and Sp... in France (11)

General Medicine and S... in Germany (11)

General Medicine and Spe... in India (12)

General Medicine and Spe... in Italy (12)

General Medicine and Spe... in Spain (11)

General Med... in the United Kingdom (12)

General Medi... in the United States (28)

Company Reports

Johnson And Johnson

GlaxoSmithKline P.L.C.

Hoya Corp.

HOYA Corp.

Abbott Medical Optics Inc.

Alcon Inc.

Carl Zeiss Inc.

Bausch And Lomb Inc.

Kao Corp.

Novartis Inc.

General Medicine And Specialty Medicine Industry in Australia : Latest Downloads

General Medicine and Specialty Medicine Business

Industry report
April 2013
35 pages

... Scientist; radiotherapy physicist clinical vascular scientist; respiratory physiologist; sleep physiologist. Consultants in: haematology; emergency medicine; old age psychiatry.. Non-consultant, non ...

General Medicine and Specialty Medicine Business Analysis

Industry report
March 2013
65 pages

General Medicine and Specialty Medicine Market Brief